ESSA Pharma Inc. (EPIX) earnings
Quarterly and annual EPIX reports and results, each read against the price at its own news timestamp. Back to the EPIX overview →
8 measured EPIX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ESSA Pharma Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.52% | |
| Form 10-Q ESSA Pharma Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.35% | -4.47% | |
| Form 10-Q ESSA Pharma Inc. For: Dec 31 | SEC filing · Form 10-Q | -3.49% | -6.39% | |
| Form 10-K ESSA Pharma Inc. For: Sep 30 | SEC filing · Form 10-K | -2.66% | -2.96% | |
| Form 10-Q ESSA Pharma Inc. For: Jun 30 | SEC filing · Form 10-Q | -3.39% | -1.91% | |
| Form 10-Q ESSA Pharma Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +3.27% | |
| Form 10-Q ESSA Pharma Inc. For: Dec 31 | SEC filing · Form 10-Q | +0.63% | +1.90% | |
| Form 10-K ESSA Pharma Inc. For: Sep 30 | SEC filing · Form 10-K | +0.76% | +4.76% |
Keep exploring
More EPIX: analyst actions → · SEC filings → · EPIX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| IsoRay, Inc. (DE) (ISR) | 722 | -0.01% | 45% |
| Pfizer, Inc. (PFE) | 721 | -0.04% | 46% |
| Tricida, Inc. (TCDA) | 715 | +0.06% | 51% |
| Apellis Pharmaceuticals, Inc. (APLS) | 714 | -0.17% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.